Pyxis Oncology Stock (NASDAQ: PYXS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 25.00 / 598.82K |
Day Range | - - - |
52 Wk Range | 1.35 - 6.85 |
Market Cap | $216.91M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 8.11% |
Days to Cover | 11.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Pyxis Oncology (NASDAQ:PYXS) through any online brokerage.
Other companies in Pyxis Oncology’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Atossa Therapeutics (NASDAQ:ATOS).
Pyxis Oncology has a consensus price target of $12.40.
The stock price for Pyxis Oncology (NASDAQ: PYXS) is $3.68 last updated September 19, 2024 at 5:57 PM EDT.
There are no upcoming dividends for Pyxis Oncology.
Pyxis Oncology’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Pyxis Oncology.
Pyxis Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.